LNTH Lantheus to Buy Evergreen Theragnostics Lantheus Holdings, Inc. (NASDAQ:LNTH) announced its second acquisition this ...

Lantheus Holdings, Inc. (NASDAQ:LNTH) agreed to acquire Evergreen Theragnostics, Inc. in an all-cash transaction involving an ...

Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LNTH stock, giving a Buy rating yesterday.Invest with Confidence: ...

Lantheus Holdings Inc. is adding to its portfolio yet again, acquiring a clinical-stage radiopharmaceutical company in a deal ...

In trading on Tuesday, shares of Lantheus Holdings Inc (Symbol: LNTH) crossed below their 200 day moving average of $92.96, changing hands as low as $90.75 per share. Lantheus Holdings Inc shares ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Lantheus (LNTH) announced the appointment of Phuong Khanh Morrow, M.D. to Lantheus’ Board of Directors, effective February 1, 2025. As an ...

Massachusetts-based radiopharmaceutical company Lantheus (Nasdaq: LNTH) has announced a plan to acquire clinical-stage ...

View Lantheus Holdings, Inc. (LNTH) current and estimated P/E ratio data provided by Seeking Alpha.

Lantheus Holdings, Inc. (LNTH) stock price is 91.13 and Lantheus Holdings, Inc. (LNTH) 10-day simple moving average is 94.66. Lantheus Holdings, Inc. (LNTH) stock price is 91.13 and Lantheus ...